ReNeuron Group plc
Company Profile
Company website
Sector
Pharmaceuticals and Biotechnology (Biotechnology)
Description
ReNeuron Group plc (AIM: RENE) is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop 'off the shelf' stem cell treatments, without the need for immunosuppressive drugs.
Investor Access
02
Dec
Event information
Management announced its unaudited interim results for the six months ended 30 September 2022 on Friday 2nd December 2022.
Venue
Online
Time
Friday 2nd December 2022
Financial Calendar
| Event | Date |
| Year End | 31 March |
| Half Year End | 30 September |
| Preliminary Results* | July |
| Interim Results* | December |
| AGM* | September |
* Months based on previous announcements of this kind
